Equity · Industrials
DLB
NYSEDolby Laboratories (DLB)
The line runs $52 on 30 July through $58.48 on 6 October, on a scale from $50 to $70. Days the market did not trade hold the previous close, flat.
- Market cap
- $5.6B
- P/E (TTM)
- 25.0
- 52-week range
- $48.51 – $73
- Avg volume
- 53.0K
as of Oct 6, 2026
Have Dolby Laboratories (DLB) insiders bought or sold shares recently?
In the 90 days to 28 Oct 2026, Dolby Laboratories insiders reported 7 open-market sales and no purchases (SEC Form 4); the filings we hold, back to 14 Oct 2025, show no open-market purchase.
Form 4, 90 days to 28 Oct 2026, newest reported trade 1 Oct 2026
Buys 0Sells 7Net sold $1.75MOther filings 8
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 01 Oct 2026 | Couling John DSVP, Entertainment | Sell | 7,667 | $451K |
| 01 Sep 2026 | Couling John DSVP, Entertainment | Sell | 7,667 | $468K |
| 25 Aug 2026 | Nicholson RyanVP, CAO and Corp. Controller | Sell | 1,183 | $77K |
| 14 Aug 2026 | Revankar ShriramSVP, Advanced Technology Group | Sell | 3,000 | $188K |
| 10 Aug 2026 | Nicholson RyanVP, CAO and Corp. Controller | Sell | 1,348 | $84K |
| 04 Aug 2026 | Nicholson RyanVP, CAO and Corp. Controller | Sell | 357 | $22K |
| 03 Aug 2026 | Couling John DSVP, Entertainment | Sell | 7,667 | $460K |
| Sold | 7 open-market sales | 28,889 | $1.75M |
8 other filings in the window: grants, exercises, tax withholding and transfers, not trades
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 01 Oct 2026 | Couling John DSVP, Entertainment | Option exercise | 7,667 | $349K |
| 15 Sep 2026 | Whitten MarcPresident and CEO | Award | 160,256 | |
| 15 Sep 2026 | Couling John DSVP, Entertainment | Award | 48,076 | |
| 15 Sep 2026 | SHERMAN MARK ANDREWEVP, Gen. Counsel & Secretary | Award | 48,076 | |
| 01 Sep 2026 | Couling John DSVP, Entertainment | Option exercise | 7,667 | $349K |
| 28 Aug 2026 | Dolby Dagmar10% Owner | Other | 300,000 | |
| 28 Aug 2026 | Dolby Dagmar10% Owner | Gift | 300,000 | |
| 03 Aug 2026 | Couling John DSVP, Entertainment | Option exercise | 7,667 | $349K |
Which funds hold Dolby Laboratories (DLB)?
10 of the 45 institutional funds we track reported a Dolby Laboratories position for the quarter ended 30 Jun 2026 — a combined $120.6M; the latest of those filings landed 02 Sep 2026.
| Fund | Position | Shares | Value | Shares q/q |
|---|---|---|---|---|
| Citadel Advisors | Added | 582,031 | $30.6M | +1,543.5% |
| Millennium Management | Held (±25%) | 420,067 | $22.1M | −2.2% |
| D. E. Shaw & Co. | Held (±25%) | 415,005 | $21.8M | +5.9% |
| Marshall Wace | Added | 343,678 | $18.1M | +464.0% |
| AQR Capital Management | Trimmed | 322,656 | $16.9M | −71.0% |
| Balyasny Asset Management | Added | 74,745 | $3.9M | +37.0% |
| Bridgewater Associates | New position | 60,275 | $3.2M | |
| Man Group | Trimmed | 33,613 | $1.8M | −57.5% |
| Two Sigma Investments | New position | 32,979 | $1.7M | |
| GAMCO Investors | Held (±25%) | 8,828 | $464K | +22.0% |
Have members of Congress traded Dolby Laboratories (DLB)?
The most recent congressional trade disclosed in Dolby Laboratories is a sale by Lisa C. McClain (house, MI), dated 25 Sep 2025.
STOCK Act disclosures
| Traded | Member | Type | Amount | Filed after |
|---|---|---|---|---|
| 25 Sep 2025 | Lisa C. McClainhouse · Republican–MI | Sale | $1K–$15K | 27 days |
| 11 Sep 2025 | Lisa C. McClainhouse · Republican–MI | Purchase | $1K–$15K | 41 days |
| 04 Aug 2025 | Lisa C. McClainhouse · Republican–MI | Sale | $1K–$15K | 39 days |
| 24 Jun 2025 | Lisa C. McClainhouse · Republican–MI | Purchase | $1K–$15K | 50 days |
What has been filed or recorded for Dolby Laboratories (DLB)?
The filings we hold for Dolby Laboratories, newest first: 3 fails-to-deliver days, 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 30 Sep 2026. No next earnings date is announced in SEC filings yet.
| And | ||||
|---|---|---|---|---|
| 30 Sep 2026 | Fails to deliver | Shares failed to deliver | 590 shares | $34K notional · 0.001% of shares out |
| 15 Sep 2026 | Fails to deliver | Shares failed to deliver | 7 shares | $433 notional · <0.001% of shares out |
| 14 Sep 2026 | Fails to deliver | Shares failed to deliver | 93 shares | $6K notional · <0.001% of shares out |
| 26 Jun 2026 | Quarterly earnings | Q3 2026 reported | EPS $0.30 | Revenue $305M |
| 26 Jun 2026 | Financials | Total assets | $3.2B | at period end |
| 26 Jun 2026 | Financials | Total equity | $2.6B | at period end |
| 27 Mar 2026 | Quarterly earnings | Q2 2026 reported | EPS $0.99 | Revenue $396M |
| 26 Dec 2025 | Quarterly earnings | Q1 2026 reported | EPS $0.55 | Revenue $347M |
| 26 Sep 2025 | Annual report | FY 2025 reported | EPS $2.62 | |
| 26 Sep 2025 | Financials | Revenue | $1.3B | fiscal year |
| 26 Sep 2025 | Financials | Net income | $255.0M | fiscal year |
| 26 Sep 2025 | Financials | Diluted EPS | $2.62 | fiscal year |
| 27 Jun 2025 | Quarterly earnings | Q3 2025 reported | EPS $0.48 | Revenue $316M |
| 28 Mar 2025 | Quarterly earnings | Q2 2025 reported | EPS $0.94 | Revenue $370M |
| 27 Dec 2024 | Quarterly earnings | Q1 2025 reported | EPS $0.70 | Revenue $357M |
| 27 Sep 2024 | Annual report | FY 2024 reported | EPS $2.69 |
Dolby Laboratories (DLB): frequently asked questions
What did Dolby Laboratories shares close at?
Dolby Laboratories closed at $58.48 on 6 Oct 2026, down 1.44% on the close before. That is the end-of-day price from Finazon, not a live quote.
What is Dolby Laboratories’ market cap?
Dolby Laboratories is worth $5.6B by market value as of 6 Oct 2026, which is the share price times the shares on issue from its SEC filings.
What is Dolby Laboratories’ P/E ratio?
Dolby Laboratories has a price-to-earnings ratio of 25.0, as of 6 Oct 2026: the share price divided by what the company earned per share over the last four reported quarters. A higher number means the market pays more for each dollar of earnings.
What is Dolby Laboratories’ revenue?
Dolby Laboratories reported revenue of $1.3B for the year ended 26 Sep 2025, as filed with the SEC. See Filings
Have Dolby Laboratories insiders bought or sold shares recently?
In the 90 days to 28 Oct 2026, Dolby Laboratories insiders reported 7 open-market sales and no purchases (SEC Form 4); the filings we hold, back to 14 Oct 2025, show no open-market purchase. A further 8 filings were grants, awards, gifts or exercises rather than open-market trades. See Insiders
Which funds own Dolby Laboratories?
10 of the 45 funds we track reported a Dolby Laboratories position for the quarter ended 30 Jun 2026, per their SEC Form 13F filings. The largest reported positions were Citadel Advisors, Millennium Management and D. E. Shaw & Co. See Funds
Have members of Congress traded Dolby Laboratories?
Yes. 4 trades in Dolby Laboratories appear in the congressional disclosures we hold; the latest is a sale by Lisa C. McClain (House, MI) dated 25 Sep 2025, filed 22 Oct 2025. Amounts are disclosed as ranges, and a filing can follow the trade by up to 45 days. See Congress
When did Dolby Laboratories last report earnings?
Dolby Laboratories last reported earnings on 26 Jun 2026 for Q3 2026, with EPS of $0.30; no next date is announced in SEC filings yet. See Filings
Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.
References
- Finazonprior-day close, indicative (IEX-derived, not the official close), most closes dollar-rounded at the source
- TradingViewthe price chart widget, drawn by TradingView from their own data
- SEC EDGARForm 4 filings (insider transactions)
- SEC EDGAR13F filings
- House disclosuresU.S. House of Representatives financial disclosures
- SECSEC fails-to-deliver (CNS) data
- SEC EDGARXBRL company facts, latest period ended 26 Jun 2026
- SEC EDGARreported earnings figures and scheduled report dates
- SEC EDGARValuation computed from SEC EDGAR filings